Nectar Lifescience Ltd.
| BSE: 532649 | Sector: Health care |
| NSE: NECLIFE | ISIN Code: INE023H01027 |
| BSE 12:10 | 22 Oct | 28.30 |
0.35 (1.25%) |
OPEN
28.75 |
HIGH
28.80 |
LOW
28.10 |
| NSE 11:59 | 22 Oct | 28.40 |
0.45 (1.61%) |
OPEN
28.25 |
HIGH
28.85 |
LOW
28.15 |
| OPEN | 28.75 |
| PREVIOUS CLOSE | 27.95 |
| VOLUME | 20394 |
| 52-Week high | 48.40 |
| 52-Week low | 16.20 |
| P/E | |
| Mkt Cap.(Rs cr) | 635 |
| Buy Price | 28.20 |
| Buy Qty | 2899.00 |
| Sell Price | 28.30 |
| Sell Qty | 452.00 |
Nectar Lifescience Ltd. (NECLIFE) - Latest News & Headlines
-
Nectar Lifescience Ltd Shareholding for the Period Ended September 30 2021
06/10/2021 | bse
-
Nectar Lifescience Ltd Statement Of Investor Complaints For The Quarter Ended September 2021
05/10/2021 | bse
-
Nectar Lifescience Ltd Closure of Trading Window
30/09/2021 | bse |
Downlaod PDF -
Nectar Lifescience Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
21/09/2021 | bse
-
Nectar Lifescience Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM
21/09/2021 | bse |
Downlaod PDF
-
Shoppers Stop surges 20% on strong operational performance in Q2
10.57 am | 21 Oct 2021 | Business Standard
The company said it witnessed a strong recovery in demand after the second wave across the formats, with sales moving swiftly close to pre-pandemic le...
-
Weak demand, high cost to keep cement firms' EBITDA muted in Q2: Centrum
11.48 pm | 18 Oct 2021 | Business Standard
Q2FY22 is generally a weak quarter for cement makers due to monsoon, but the quarter under preview has also been affected by rising coal and pet coke ...
-
UltraTech Q2 net profit flat at Rs 1,310 cr, revenue rises 16%
11.46 pm | 18 Oct 2021 | Press Trust of India
During the quarter, UltraTech's consolidated sales volume was at 21.64 million metric tons, registering a year-on-year growth of 8%
-
Chennai Super Kings looks set to become India's first sports unicorn
9.44 am | 18 Oct 2021 | Business Standard
May even overtake parent company India Cements' m-cap: Experts
-
This Radhakishan Damani-owned stock hits over 13-yr high on robust outlook
12.53 pm | 14 Oct 2021 | Business Standard
India Cements rallied 11 per cent to Rs 221.80 on the BSE today, trading at its highest level since February 2008
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
